cgp 12177 has been researched along with Leukemia, Myeloid, Acute in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sager, G | 1 |
| Bang, BE | 1 |
| Pedersen, M | 1 |
| Aarbakke, J | 1 |
1 other study available for cgp 12177 and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
The human promyelocytic leukemia cell (HL-60 cell) beta-adrenergic receptor.
Topics: Cyclic AMP; Humans; Isoproterenol; Leukemia, Myeloid, Acute; Propanolamines; Receptors, Adrenergic, | 1988 |